Breast Cancer

Atlantic Health System is feeling a little blue, but not in a melancholy kind of way. Horizon Blue Cross Blue Shield just named us one of their Blue Distinction® Centers for Cancer Care, which recognizes quality in value-based care. The designation applies to all cancer types in various settings, including Chilton Medical Center and other Atlantic Health System hospitals, physician groups, cancer centers and accountable care organizations.
Learn more >





Breast Cancer Programs and Screenings

Education and prevention can keep you and your loved ones healthy. We invite you to take advantage of the programs, support groups and screenings available.

Cancer Support Group for Men and Women
Men and women who are newly diagnosed with cancer, in treatment or up to two years post treatment can learn more about their condition, while sharing information and encouragement with others.
Second Tuesday of every month, 1:30 to 3:00pm
Chilton Medical Center Collins Pavilion, 1st Floor Cancer Conference Room
97 West Parkway, Pompton Plains, NJ
For more information and to register, please call 973-831-5311.


Breast Cancer Articles
Read more

Therapeutic Vaccine Shows Promise Against a Range of Cancers

MONDAY, Oct. 1, 2018 -- A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, researchers report.

HER2-positive cancers are cancers that have too much of the HER2 protein on their surface. In that setting, a cancer can grow rapidly and be more likely to spread to other areas of the body. Areas known to have HER2-positive cancers include the breasts, bladder, pancreas, ovaries and stomach.

Read more

Breast Cancer Treatment Adherence Rates Vary by Race

TUESDAY, Sept. 25, 2018 -- Black women are more likely than white women to skip important hormonal breast cancer treatments, new research indicates.

Endocrine therapy is used to add, block or get rid of naturally occurring hormones like estrogen and progesterone that trigger certain types of breast cancer, the study authors explained. Previous studies have shown that 10 years of endocrine therapy reduces the odds for disease recurrence.

Read more